Stock Track | IDEXX Laboratories Soars 8.21% on Strong Q1 Earnings Beat and Raised 2025 Outlook

Stock Track

May 01, 2025

Shares of IDEXX Laboratories (IDXX) surged 8.21% in pre-market trading on Thursday after the animal diagnostics company reported better-than-expected first quarter earnings and raised its full-year guidance.

IDEXX posted earnings per share of $2.96 for Q1 2025, surpassing the FactSet analyst consensus estimate of $2.85. Revenue came in at $998.4 million, slightly above analyst expectations of $997.1 million. The company's gross margin expanded to 62.4% from 61.5% in the year-ago quarter, while operating margin improved to 31.7% from 31.0%.

Investors were particularly encouraged by IDEXX's raised outlook for 2025. The company now expects full-year earnings per share of $11.93 to $12.43, up from its previous guidance of $11.74 to $12.24. IDEXX also boosted its revenue growth forecast to 5-8%, with projected revenue of $4.10 billion to $4.21 billion.

The strong results were driven by solid performance across IDEXX's business segments. Companion Animal Group diagnostics recurring revenue, a key metric for the company, grew 4.5% organically. IDEXX's water testing and livestock/poultry diagnostics segments also showed healthy growth. The company's ongoing focus on innovation and expanding its diagnostic offerings continues to drive market share gains in the veterinary sector.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1196647109"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1196647109\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1196647109?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-01 21:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1196647109","market":"us","top_or_hot":-1,"title":"Stock Track | IDEXX Laboratories Soars 8.21% on Strong Q1 Earnings Beat and Raised 2025 Outlook","media":"Stock Track","content":"<p>Shares of IDEXX Laboratories (IDXX) surged 8.21% in pre-market trading on Thursday after the animal diagnostics company reported better-than-expected first quarter earnings and raised its full-year guidance.</p>\n\n<p>IDEXX posted earnings per share of $2.96 for Q1 2025, surpassing the FactSet analyst consensus estimate of $2.85. Revenue came in at $998.4 million, slightly above analyst expectations of $997.1 million. The company's gross margin expanded to 62.4% from 61.5% in the year-ago quarter, while operating margin improved to 31.7% from 31.0%.</p>\n\n<p>Investors were particularly encouraged by IDEXX's raised outlook for 2025. The company now expects full-year earnings per share of $11.93 to $12.43, up from its previous guidance of $11.74 to $12.24. IDEXX also boosted its revenue growth forecast to 5-8%, with projected revenue of $4.10 billion to $4.21 billion.</p>\n\n<p>The strong results were driven by solid performance across IDEXX's business segments. Companion Animal Group diagnostics recurring revenue, a key metric for the company, grew 4.5% organically. IDEXX's water testing and livestock/poultry diagnostics segments also showed healthy growth. The company's ongoing focus on innovation and expanding its diagnostic offerings continues to drive market share gains in the veterinary sector.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | IDEXX Laboratories Soars 8.21% on Strong Q1 Earnings Beat and Raised 2025 Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | IDEXX Laboratories Soars 8.21% on Strong Q1 Earnings Beat and Raised 2025 Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-05-01 21:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of IDEXX Laboratories (IDXX) surged 8.21% in pre-market trading on Thursday after the animal diagnostics company reported better-than-expected first quarter earnings and raised its full-year guidance.</p>\n\n<p>IDEXX posted earnings per share of $2.96 for Q1 2025, surpassing the FactSet analyst consensus estimate of $2.85. Revenue came in at $998.4 million, slightly above analyst expectations of $997.1 million. The company's gross margin expanded to 62.4% from 61.5% in the year-ago quarter, while operating margin improved to 31.7% from 31.0%.</p>\n\n<p>Investors were particularly encouraged by IDEXX's raised outlook for 2025. The company now expects full-year earnings per share of $11.93 to $12.43, up from its previous guidance of $11.74 to $12.24. IDEXX also boosted its revenue growth forecast to 5-8%, with projected revenue of $4.10 billion to $4.21 billion.</p>\n\n<p>The strong results were driven by solid performance across IDEXX's business segments. Companion Animal Group diagnostics recurring revenue, a key metric for the company, grew 4.5% organically. IDEXX's water testing and livestock/poultry diagnostics segments also showed healthy growth. The company's ongoing focus on innovation and expanding its diagnostic offerings continues to drive market share gains in the veterinary sector.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IDXX","symbol_name":"爱德士实验室","start_time":0,"source_url":"","article_id":"1196647109","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1196647109","pubTimestamp":1746106834,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of IDEXX Laboratories  surged 8.21% in pre-market trading on Thursday after the animal diagnostics company reported better-than-expected first quarter earnings and raised its full-year guidance.IDEXX posted earnings per share of $2.96 for Q1 2025, surpassing the FactSet analyst consensus estimate of $2.85. Revenue came in at $998.4 million, slightly above analyst expectations of $997.1 million. The company's gross margin expanded to 62.4% from 61.5% in the year-ago quarter, while operatin","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IDXX":"爱德士实验室"},"translate_title":"股票跟踪IDEXX Laboratories因第一季度盈利强劲增长并上调2025年前景而飙升8.21%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IDXX":1},"content_text":"Shares of IDEXX Laboratories (IDXX) surged 8.21% in pre-market trading on Thursday after the animal diagnostics company reported better-than-expected first quarter earnings and raised its full-year guidance.\nIDEXX posted earnings per share of $2.96 for Q1 2025, surpassing the FactSet analyst consensus estimate of $2.85. Revenue came in at $998.4 million, slightly above analyst expectations of $997.1 million. The company's gross margin expanded to 62.4% from 61.5% in the year-ago quarter, while operating margin improved to 31.7% from 31.0%.\nInvestors were particularly encouraged by IDEXX's raised outlook for 2025. The company now expects full-year earnings per share of $11.93 to $12.43, up from its previous guidance of $11.74 to $12.24. IDEXX also boosted its revenue growth forecast to 5-8%, with projected revenue of $4.10 billion to $4.21 billion.\nThe strong results were driven by solid performance across IDEXX's business segments. Companion Animal Group diagnostics recurring revenue, a key metric for the company, grew 4.5% organically. IDEXX's water testing and livestock/poultry diagnostics segments also showed healthy growth. The company's ongoing focus on innovation and expanding its diagnostic offerings continues to drive market share gains in the veterinary sector.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}